The protective effect of probucol on adriamycin nephrosis in the rat.
Recent research has indicated the role of reactive oxygen species (ROS) in experimental nephritis. We examined the role of ROS and the effect of probucol, an anti-hyperlipidemic drug with antioxidant activity, on adriamycin (ADR)-induced nephrosis in the rat. Fourteen days after single intravenous injection of ADR (7.5 mg/kg b.w.), a nephrotic state was observed. Compared with the normal control values, the total kidney glutathione content was lower on day 5, but significantly higher on day 14 in the ADR-injected rats. Feeding ADR-injected rats with food containing 1% probucol was effective in reducing urinary protein excretion. Serum lipid peroxide level and kidney total glutathione content, both of which increased on day 14 in the ADR-injected rats, were also decreased significantly by concomitant probucol treatment. During long-term observation period of 18 weeks, probucol treatment relieved both urinary protein excretion and the progression of renal impairment. These protective effects of probucol suggest a role of ROS in the induction and progression of ADR nephrosis.
Futenma
A
A
First Department of Internal Medicine, Aichi Medical University, Japan.
Miyai
H
H
Iida
T
T
Hara
T
T
Watanabe
T
T
Shiono
S
S
Fukatsu
A
A
Kato
K
K
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects*; D008297:Male; D009393:Nephritis / Q000139:chemically induced* / Q000517:prevention & control*; D011341:Probucol / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species
D000903:Antibiotics, Antineoplastic; D000924:Anticholesteremic Agents; D000975:Antioxidants; D017382:Reactive Oxygen Species; D004317:Doxorubicin; D011341:Probucol